Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and current treatments are not long lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of osteoarthritis treatments on offer to meaningfully help patients – until now.

Decoding the Choice: A Step-by-Step Patient Guide to Selecting the Best Knee Gel Injection for Osteoarthritis Relief
Explore comprehensive insights into knee gel injections for osteoarthritis, including hyaluronic acid, polyacrylamide hydrogel (PAAG), and platelet-rich plasma (PRP). This guide compares efficacy, treatment schedules, and suitability based on severity, age, and lifestyle. Discover how PAAG offers longer-lasting relief with a single injection, while HA and PRP provide alternatives suited to different patient needs. Supported by recent studies, understand the benefits, risks, and how to make informed decisions with your healthcare provider for personalized osteoarthritis management.
